If NanoSomiX Inc has a test that can truly predict
Post# of 30066
Posted On: 01/04/2015 9:37:09 AM
Quote:
If NanoSomiX Inc has a test that can truly predict a decade in advance at the specs they are reporting...Why in the world would they be interested in acquiring lympro?
It's the other way around. Amarantus is looking at acquiring other diagnostic asset(s) per what they said the last few months.
Keep in mind, I didn't say they Amarantus was interested in acquiring NanoSomiX, but it's likely they would acquire a small, very promising bio company like NanoSomiX as an example.
If Amarantus did acquire NanoSomiX, the irony is there would be a lot of bitching and moaning on all 3 message boards about what a dumb acquisition it was to purchase a company with products so far off in the future, more dilution to fund the research, no revenues, and a CEO Navy guy with a MBA and Engineering degree.
Dec. 22, 2014 - "Moving forward, we expect to announce additional significant news in the coming weeks regarding LymPro, as well as pending additions to our diagnostics division to buttress this business unit for a potential spin-off into a standalone entity."
Nov. 18, 2014 - AMBS Near-Term Milestone: Preparation for potential spin-out of diagnostics division (potential stock dividend to shareholders)
Oct. 27, 2014 - "We are actively evaluating additional complementary late-stage neurology-focused diagnostic assets that would bolster our diagnostic division and make for a successful ‘spin-out’ while concurrently returning value to our shareholders. We believe we will be able to execute on this strategy in the near-term."
(0)
(0)